0 NYSE Companies - January 7, 2019Ooma Introduces Advanced Wireless Home Phone Using Sprint Nationwide 4G NetworkSUNNYVALE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — Ooma, Inc., a smart communications platform for businesses and consumers, today announced […]Read More
0 NYSE Companies - January 7, 2019Inspire Medical Systems, Inc. Announces Issuance of Positive Assessment for Inspire Therapy by Blue Cross Blue Shield Association’s Evidence StreetMINNEAPOLIS, Minn., Jan. 07, 2019 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused […]Read More
0 NYSE Companies - January 7, 2019Rafael Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNewark, NJ, Jan. 07, 2019 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael”), a leader in the field of cancer metabolism, […]Read More
0 NYSE Companies - January 7, 2019Hersha Hospitality Trust to Report Fourth Quarter 2018 Earnings on February 25, 2019PHILADELPHIA, Jan. 07, 2019 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of high-quality upscale, […]Read More
0 NASDAQ Companies - January 7, 2019Caladrius Biosciences to Participate in Upcoming January ConferencesBasking Ridge, New Jersey, Jan. 07, 2019 (GLOBE NEWSWIRE) — Caladrius Biosciences to Participate in Upcoming January Conferences BASKING RIDGE, […]Read More
0 NASDAQ Companies - January 7, 2019Alta Mesa Announces Appointment of John C. Regan as Chief Financial OfficerHOUSTON, Jan. 07, 2019 (GLOBE NEWSWIRE) — Alta Mesa Resources, Inc. (NASDAQ: AMR, “Alta Mesa Resources” or the “Company”) today […]Read More
0 NASDAQ Companies - January 7, 2019Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients— 12 of 13 (92%) patients achieved a complete response — — Results from 3 additional cohorts expected in the […]Read More
0 NASDAQ Companies - January 7, 2019Immutep Enters Into Clinical Trial Collaboration, Service and Supply Agreement With CYTLIMICNew clinical trial collaboration with CYTLIMIC to test eftilagimod alpha (“efti” or “IMP321”) as part of a cancer peptide vaccine […]Read More
0 NASDAQ Companies - January 7, 2019Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene TherapyPreparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years Recently Announced Clinical […]Read More
0 NASDAQ Companies - January 7, 2019University of Rochester Medical Center Reduces Risk of Delayed Diagnoses with Nuance Diagnostic SolutionsNuance’s mPower Clinical Analytics and PowerScribe Follow-up Manager drive follow-up on incidental findings and improve patient outcomes at URMC BURLINGTON, […]Read More